Intracerebral haemorrhage (ICH ) comprises about more likely the all too common problem of a failure to comply with medical advice. Although it was not 10-15% of strokes and is associated with a high mortality rate and a high level of persistent disability possible to directly attribute this increased risk of ICH among people ceasing antihypertensive therapy to the in survivors [1,2]. Because there is little potential to ameliorate the damage after ICH has occurred, preven-absolute increases in levels of blood pressure (blood pressure was not measured in these people prior to tion is of particular importance.
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There is now quite clear evidence that hypertension their ICH ), this seems a reasonable explanation. The higher risk of ICH in such patients, therefore, is the most powerful risk factor for ICH. In a recent case-control study that involved 331 cases of primary emphasises the importance of continuing (and indeed improving) therapy and adequate blood pressure mon-ICH and the same number of matched controls, the adjusted odds ratio (OR) for ICH among hypertensives itoring, as well as encouraging compliance, in patients with established hypertension. Because of the prevalwas 2.45 (95% confidence interval (CI ) 1.61-3.73) [3] . A similar OR was obtained when patients who had ence and severity of hypertension among patients with renal diseases, these findings are of particular imporever used antihypertensive medication were considered (OR 2.44, 95% CI 1.56-3.82). Although these ORs are tance among this group of patients. generally less than those reported in most previous studies of the condition [4-9] they are similar to the Implications for patients with renal disease only other major Australian study [10] . The relatively low ORs might partly be explained by the high level Although many factors probably contribute to the of detection and management of hypertension in dramatically increased risk of ICH in chronic haemoAustralia, as well as other population differences, dialysis patients, there is clear evidence for a major including the prevalence of smoking and other risk role of hypertension [12, 13] . Furthermore, the prevalfactors for ICH [11] .
ence and severity of hypertension in this group of patients might also suggest that they are at increased risk of ICH [14] . Aggressive treatment of hypertension,
Ceasing antihypertensive medication use increases
with lower than normal target blood pressure, has the risk of ICH been recommended for patients with renal failure, particularly those on haemodialysis [12,13]. A major finding of the study was that the stroke risk
To maximize the value of antihypertensive therapy among hypertensives varied according to their current to these patients, consideration must be given to the or past use of antihypertensive medication [3] . When issues of compliance, antihypertensive efficacy, and the compared to never users of antihypertensive medica-renoprotective value of the various therapeutic altertions (i.e. normotensives and undetected hypertensives) natives. At least in lower socio-economic groups, the OR for current users was 1.95 (95% CI 1.20-3.16). decreased satisfaction with patient care and with interThe level of risk was significantly greater (P=0.002) personal relationships with physicians, correlate with among those who had received antihypertensive med-decreased antihypertensive compliance [15] . The type ications in the past but had subsequently ceased this of antihypertensive agent used appears to influence use (OR 4.98, 95% CI 2.25-11.02). This observation compliance, it being greater for angiotensin converting supports the notion that antihypertensive therapy enzyme inhibitors and calcium antagonists than for reduces the risk of ICH among hypertensive patients. beta-blockers and diuretics, possibly because of a It is unlikely that patients ceased their antihypertensive reduced incidence of side-effects, particularly with comtherapy because their blood pressure had normalized; bination therapies [16 ] . The former agents also prob- 
